The U.S. Food and Drug Administration announced the approval of Aquaflor (florfenicol), including two new indications, an increased maximum dose, and a single withdrawal period for all approved uses. Aquaflor is now approved for the control of mortality due to streptococcal septicemia (freshwater-reared warmwater finfish), columnaris disease (ALL freshwater-reared finfish), enteric septicemia (catfish), furunculosis and coldwater disease (freshwater-reared salmonids). Click here for more information about the new approval, and be sure to check out the Guide to Using Drugs, Biologics, and Other Chemicals for more information about disease management in aquaculture.